Shield Therapeutics Balance Sheet Health
Financial Health criteria checks 3/6
Shield Therapeutics has a total shareholder equity of $541.0K and total debt of $19.7M, which brings its debt-to-equity ratio to 3637.5%. Its total assets and total liabilities are $46.8M and $46.2M respectively.
Key information
3,637.5%
Debt to equity ratio
US$19.68m
Debt
| Interest coverage ratio | n/a |
| Cash | US$8.10m |
| Equity | US$541.00k |
| Total liabilities | US$46.22m |
| Total assets | US$46.76m |
Recent financial health updates
Shield Therapeutics (LON:STX) Is Making Moderate Use Of Debt
Oct 12
Here's Why We're Watching Shield Therapeutics' (LON:STX) Cash Burn Situation
Mar 02We're Interested To See How Shield Therapeutics (LON:STX) Uses Its Cash Hoard To Grow
Jan 27
Recent updates
Shield Therapeutics plc (LON:STX) Stock's 28% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Oct 30Shield Therapeutics (LON:STX) Is Making Moderate Use Of Debt
Oct 12Shield Therapeutics plc's (LON:STX) Shares Leap 44% Yet They're Still Not Telling The Full Story
Aug 01Increases to Shield Therapeutics plc's (LON:STX) CEO Compensation Might Cool off for now
Jun 13Market Might Still Lack Some Conviction On Shield Therapeutics plc (LON:STX) Even After 35% Share Price Boost
May 22Here's Why We're Watching Shield Therapeutics' (LON:STX) Cash Burn Situation
Mar 02What Does The Future Hold For Shield Therapeutics plc (LON:STX)? These Analysts Have Been Cutting Their Estimates
May 06Shield Therapeutics (LON:STX) Shareholders Have Enjoyed An Impressive 111% Share Price Gain
Mar 15We're Interested To See How Shield Therapeutics (LON:STX) Uses Its Cash Hoard To Grow
Jan 27Trade Alert: The CEO & Director Of Shield Therapeutics plc (LON:STX), Timothy Watts, Has Just Spent UK£70k Buying 22% More Shares
Dec 15Financial Position Analysis
Short Term Liabilities: STX's short term assets ($27.8M) exceed its short term liabilities ($26.5M).
Long Term Liabilities: STX's short term assets ($27.8M) exceed its long term liabilities ($19.7M).
Debt to Equity History and Analysis
Debt Level: STX's net debt to equity ratio (2140.5%) is considered high.
Reducing Debt: STX's debt to equity ratio has increased from 0% to 3637.5% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: STX has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: STX has sufficient cash runway for 1.1 years if free cash flow continues to reduce at historical rates of 32.1% each year.